| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |